Acurx Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Acurx Pharmaceuticals, Inc.

Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has compl…

Biotechnology
US, Staten Island [HQ]

News

Theses · Events · Sentiments
End of ACXP's Analysis
CIK: 1736243 CUSIP: 00510M104 ISIN: US00510M1045 LEI: - UEI: -
Secondary Listings
ACXP has no secondary listings inside our databases.